• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

N Engl J Med. Epidemic Profile of Shiga-Toxin?Producing Escherichia coli O104:H4 Outbreak in Germany

Giuseppe

Emeritus
[Source: The New England Journal of Medicine, full text: (LINK). Abstract, edited.]

Epidemic Profile of Shiga-Toxin?Producing Escherichia coli O104:H4 Outbreak in Germany



Christina Frank, Ph.D., Dirk Werber, D.V.M., Jakob P. Cramer, M.D., Mona Askar, M.D., Mirko Faber, M.D., Matthias an der Heiden, Ph.D., Helen Bernard, M.D., Angelika Fruth, Ph.D., Rita Prager, Ph.D., Anke Spode, M.D., Maria Wadl, D.V.M., Alexander Zoufaly, M.D., Sabine Jordan, M.D., Markus J. Kemper, M.D., Per Follin, M.D., Ph.D., Luise M?ller, M.Sc., Lisa A. King, M.P.H., Bettina Rosner, Ph.D., Udo Buchholz, M.D., M.P.H., Klaus Stark, M.D., Ph.D., and G?rard Krause, M.D., Ph.D. for the HUS Investigation Team

October 26, 2011 (10.1056/NEJMoa1106483)

Abstract

Background

We describe an outbreak of gastroenteritis and the hemolytic?uremic syndrome caused by Shiga-toxin?producing Escherichia coli in Germany in May, June, and July, 2011. The consumption of sprouts was identified as the most likely vehicle of infection.


Methods

We analyzed data from reports in Germany of Shiga-toxin?producing E. coli gastroenteritis and the hemolytic?uremic syndrome and clinical information on patients presenting to Hamburg University Medical Center (HUMC). An outbreak case was defined as a reported case of the hemolytic?uremic syndrome or of gastroenteritis in a patient infected by Shiga-toxin?producing E. coli, serogroup O104 or serogroup unknown, with an onset of disease during the period from May 1 through July 4, 2011, in Germany.


Results

A total of 3816 cases (including 54 deaths) were reported in Germany, 845 of which (22%) involved the hemolytic?uremic syndrome. The outbreak was centered in northern Germany and peaked around May 21 to 22. Most of the patients in whom the hemolytic?uremic syndrome developed were adults (88%; median age, 42 years), and women were overrepresented (68%). The estimated median incubation period was 8 days, with a median of 5 days from the onset of diarrhea to the development of the hemolytic?uremic syndrome. Among 59 patients prospectively followed at HUMC, the hemolytic?uremic syndrome developed in 12 (20%), with no significant differences according to sex or reported initial symptoms and signs. The outbreak strain was typed as an enteroaggregative Shiga-toxin?producing E. coli O104:H4, producing extended-spectrum beta-lactamase.


Conclusions


In this outbreak, caused by an unusual E. coli strain, cases of the hemolytic?uremic syndrome occurred predominantly in adults, with a preponderance of cases occurring in women. The hemolytic?uremic syndrome developed in more than 20% of the identified cases.
-
-----
 
Back
Top